Skip to main content

Advertisement

Log in

Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches

  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Fatigue is a common symptom in multiple sclerosis (MS). As fatigue includes a variety of aspects, its treatment is best approached in a multidisciplinary fashion that includes nonpharmacological interventions and medications. In individuals with mild fatigue non-pharmacological treatment including yoga, aerobic exercises, cooling therapy and energy conservation techniques might be considered. Several pharmacological treatments for patients with significant fatigue have proved to be effective. Among these agents, amantadine and aminopyridines are the most frequently used. More recently also aspirin and carnitine have been used to treat MS fatigue but they need to be confirmed in larger studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Pozzilli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pozzilli, C., Sbardella, E., De Giglio, L. et al. Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches. Neurol Sci 27 (Suppl 4), s297–s299 (2006). https://doi.org/10.1007/s10072-006-0644-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-006-0644-5

Key words

Navigation